Lavinia Life Sciences Private Limited - Due diligence report

A 360° intelligence report on Lavinia Life Sciences Private Limited: trust score, financial health, credit view, compliance, directors, grow…

2018-11-30 Navi Mumbai, Maharashtra Active Unlisted
Share
Connect MCP
LL Lavinia Life Sciences Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Lavinia Life Sciences Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
72/100
Trust Score
Moderate

Lavinia Life Sciences Private Limited is assessed as Moderate with a Trust Score of 72/100. Lavinia Life Sciences Private Limited is an active private limited indian non-government company incorporated in 2018, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 10 Aug 2026 from the latest processed filings. Lavinia Life Sciences Private Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
72/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
40/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
20/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 20/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 38%).

Charges position: 2 open (9.75 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Others2 48.0 cr
Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SHYAM PURUSHOTHAMAN NAIR 01234567 Director 01/04/2018 6 yrs Approved
NEELAM SANDEEP MHATRE 01234567 Director 01/04/2018 6 yrs Approved
SANDIP PRAMOD MHATRE 01234567 Director 01/04/2018 6 yrs Approved
VIJAYKUMAR VAZAKTTUVALIYA RAGHAVAN NAIR 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Celogen Pharma Private Limited
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Celogen Pharma Private Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 85 · Distress 65
Growth signals & trust indicators
Revenue acceleration: +1.42 over 3 year(s).
Latest year revenue grew 2.1x.
Asset base grew 24% - capacity expansion.
Operating for 7 years.
Distress signals & risk flags
Losses deepening year-on-year.
Outside liabilities up 0.86 in a year.
2 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence76/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment43/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 9.75 cr already registered.
  • Compliance record supports lending.
Investor view66/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 11 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
31 Dec 2020
Director ceased
NEELAM SANDEEP MHATRE
Director ceased
SANDIP PRAMOD MHATRE
24 Dec 2020
Charge created
Others - 5.25 cr
Charge created
Others - 4.50 cr
03 Jan 2020
Director appointed
NEELAM SANDEEP MHATRE (Director)
Director appointed
SANDIP PRAMOD MHATRE (Director)
30 Nov 2018
Incorporated
Registered with Roc Mumbai
Director appointed
SHYAM PURUSHOTHAMAN NAIR (Director)
Director appointed
VIJAYKUMAR VAZAKTTUVALIYA RAGHAVAN NAIR (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 61% over the last 3 financial year(s).
Debt-to-equity stands at 38% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Nitcopaints U24220MH1981PTC024652 Mumbai, Maharashtra, India
Proethic Pharmaceuticals Private Limited U24232DL2009PTC195127 Delhi, Delhi, India
Swaraj Coatings Private Limited U24222KL1999PTC013233 Calicut, Kerala, India
A-One Dyes And Chemicals Pvt Ltd U24113MH1984PTC032690 Mumbai, Maharashtra, India
Newgen Life Sciences Private Limited U51397TN2008PTC066265 Chennai, Tamil Nadu, India
Mainavi Pharma U36990TG2020PTC140549 Hyderabad, Telangana, India
Xcel Polymer Products Private Limited U24134MP2011PTC026803 Bardari, Madhya Pradesh, India
Younker Pharmaceutical Private Limited U24290UP2017PTC095240 Ghaziabad, Uttar Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Lavinia Life Sciences Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Lavinia Life Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 20/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 85/100, margin trends, ownership structure and peer set for Lavinia Life Sciences Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 72/100, distress signals and MSME payment-delay disclosures - know whether Lavinia Life Sciences Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Lavinia Life Sciences Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Lavinia Life Sciences Private Limited an active company?

Lavinia Life Sciences Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Lavinia Life Sciences Private Limited financially healthy?

Lavinia Life Sciences Private Limited has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Lavinia Life Sciences Private Limited?

Its overall Trust Score is 72/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Lavinia Life Sciences Private Limited?

The ultimate holding entity is Celogen Pharma Private Limited. 4 active director(s) are on record.

Does Lavinia Life Sciences Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets.

Is Lavinia Life Sciences Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Lavinia Life Sciences Private Limited?

Its Credit Risk Score is 20/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.